'Cddp' presentation slideshows

CHEMOTHERAPY IN ADVANCED NSCLC

621 views • 37 slides

STAGE IV

NSCLC. STAGE IV. Stage IV NAVELBINE : The pivotal drug GEMZAR : Main competitor TAXOL : Still often prescribed TAXOTERE : New comer. NSCLC Main Drugs. or. NVB - GEM. NVB single agent. Patients not candidate for poly CT. 1 st Line Metastatic NSCLC Stage IV patients.

501 views • 32 slides

AIOM PostASCO Review - Bologna, 19 giugno 2010

ASCO NEWS 2010 HEAD & NECK Marco Benasso Oncologia Medica - Savona. AIOM PostASCO Review - Bologna, 19 giugno 2010. ASCO 2010 H&N TOPICS. TT other than Cetuximab ? Which is the best CT/RT combination ? Which is the role of TT into a CT/RT combination ?

452 views • 27 slides

Locally advanced non resectable disease (III A non resectable, III B , bulky N2)

NSCLC. CT and RT combination. Locally advanced non resectable disease (III A non resectable, III B , bulky N2). Chemotherapy + radiotherapy. 3 modalities of administration. Sequential CT-RT Concomitant CT-RT Radiosensitization. Stage IIIB RT/CT

296 views • 18 slides

NON SMALL CELL LUNG CANCER

NON SMALL CELL LUNG CANCER. Recent CT evolutions of Non Small Cell Lung Cancer. Arrival of new oral formulations Development of multimodal treatments Development of chemotherapy for early stages. Role of chemotherapy in Non Small Cell Lung Cancer. STAGE III:

374 views • 11 slides

GAPDH

40. B. 30. DMSO. CDDP (10 μ M). Apoptosis (% of Total). TAp73 α. 80 kDa. 20. ∆Np73 α. 70 kDa. P53. ***. 53 kDa. 10. GAPDH. 38 kDa. TAp73 α /GAPDH. 1.0 0.5 0.3 0.8 0.4 0.3 0.2 0.1 0.2 0.1. 0.

185 views • 3 slides

??????? ; ?????????????????????

??????? ; ?????????????????????. ????? cisplatin ? CDDP ????????????????????????????????????????????????????????????????? CDDP ????????????

101 views • 2 slides